Ref ID: 19400
Author:
O. Lortholary,1 D. Bitar,2 Y.Le Strat,2 J. Nicolau,2 B. Coignard,2
P. Tattevin,3 D. Che2 and F. Dromer1
Author address:
1Institut Pasteur, Paris, France; 2InVS, St Maurice, France and
3CHU Pontchaillou, Rennes, France
Full conference title:
6th Trends in Medical Mycology 2013
Date: 11 October 2014
Abstract:
Objectives Trends of invasive fungal infections (IFI) are changing in
relation with at risk populations. Benchmark estimates of the IFI bur-
den at country level are needed to identify priority areas for
improved prevention and control.
Methods The incidence, lethality, trends and risk factors (RF) of the
five most frequent IFIs registered in the French hospital discharge
database, during 2001-2010, were analysed.
Results There were 35,876 incident IFIs including candidemia
(43.3%), Pneumocystis jirovecii pneumonia (Pjp: 26.1%), invasive
aspergillosis (IA: 23.9%), cryptococcosis (5.2%) and mucormycosis
(1.5%). The overall incidence was 5.9 cases/100,000persons/year
and lethality was 27.6%. Annual incidences increased over time for
candidemia, IA and mucormycosis (+7.8%, +4.4%, +7.3%) and
decreased for Pjp and cryptococcosis (8.5% and 9.8%), respec-
tively (P < 0.001). Pjp incidence decreased in AIDS patients
(14.3%), but increased together with a higher lethality in seronega-
tive cases (+13,3% and +5.6%), respectively (P < 0.001). Candidemia
and IA annual incidences increased in patients with hematological
malignancies (HM) (+5.8% and +4.3% respectively, P < 0.001). Can-
didemia, IA and Pjp annual incidence increased in patients with
chronic renal failure (> +10% each, P < 0.001). The risk of death
was significantly increased in HM-associated candidemia, IA, muco-
rmycosis, and non-AIDS cryptococcosis; in tumors-associated candi-
demia, IA, and non-AIDS Pjp; and in cirrhosis-associated
candidemia, IA, and non-AIDS Pjp or cryptococcosis.
Conclusion IFI now represent a major public health priority in
developed countries.
Abstract Number: p118
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a